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In the present study, we investigate the inhibitory effect of novel H2S donors, AP67 and AP72 on isolated bovine posterior ciliary arteries (PCAs) under conditions of tone induced by an adrenoceptor agonist.  Furthermore, we examined the possible mechanisms underlying the AP67- and AP72-induced relaxations. Isolated bovine PCA were set up for measurement of isometric tension in organ baths containing oxygenated Krebs solution. The relaxant action of H2S donors was studied on phenylephrine-induced tone in the absence or presence of enzyme inhibitors for the following pathways: cyclooxygenase (COX); H2S; nitric oxide and the ATP-sensitive K+ (KATP) channel. The H2S donors, NaHS (1 nM - 10 µM), AP67 (1 nM - 10 µM) and AP72 (10 nM - 1 µM) elicited a concentration-dependent relaxation of phenylephrine-induced tone in isolated bovine PCA. While the COX inhibitor, flurbiprofen (3 µM) blocked significantly (p < 0.05) the inhibitory response elicited by AP67, it had no effect on relaxations induced by NaHS and AP72. Both aminooxyacetic acid (30 μM) and propargylglycine (1 mM), enzyme inhibitors of H2S biosynthesis caused significant (p < 0.05) rightward shifts in the concentration-response curve to AP67 and AP72.  Furthermore, the KATP channel antagonist, glibenclamide (300 µM) and the NO synthase inhibitor, L-NAME (100 µM) significantly attenuated (p < 0.05) the relaxation effect induced by AP67 and AP72 on PCA. We conclude that H2S donors can relax pre-contracted isolated bovine PCA, an effect dependent on endogenous production of H2S. The inhibitory action of only AP67 on pre-contracted PCA may involve the production of inhibitory endogenous prostanoids.  Furthermore, the observed inhibitory action of H2S donors on PCA may depend on the endogenous biosynthesis of NO and by an action of KATP channels. 
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Introduction
For decades, hydrogen sulfide (H2S) was best known as toxic environmental pollutant until recent studies provided evidence that this gas can serve as a key regulator of several physiologic and pathophysiological processes in animals. H2S is endogenously produced in mammalian tissues from amino acids, L-cysteine and homocysteine in the presence of enzymes of the sulfur metabolic network i.e. cystathionine β-synthase (CBS), cystathionine λ-lyase (CSE) and 3-mercaptopyruvate sulfurtransferase (3MST) along with cysteine aminotransferase (CAT).  The biological roles of H2S as a gaseous transmitter are multiple and rapidly expanding in most organ systems including the central and peripheral nervous systems, and the cardiovascular, gastrointestinal and respiratory systems. H2S was recently described as a vasodilator and an endothelium-hyperpolarizing factor (EDHF) candidate produced in the vascular tissues, mesenteric arteries, hepatic arteries and aorta of various species like rat, mouse and rabbits (Kimura, 2010). This vasodilatory response can be due to a variety of mechanisms like activation of  phospholipase A2,  inhibition of  phosphodiesterase, secretion of  adipocyte-derived relaxing factor (that opens voltage-dependent Kþ (Kv) channels), activation of large-conductance Ca2+-activated K+ (BKCa) channels and activation of ATP-sensitive K+ (KATP) channels ( ADDIN REFMGR.CITE Mustafa et al., 2009a; Mustafa et al., 2009b). 
In the eye, studies from our laboratory showed that H2S can be endogenously produced in ocular tissues using H2S- releasing compounds and that this gas can induce relaxation of pre-contracted porcine irides, alter sympathetic and excitatory amino acid transmission and regulate signal transduction processes in mammalian retina ( ADDIN REFMGR.CITE Chitnis et al., 2013; Kulkarni et al., 2009; Kulkarni et al., 2011; Monjok et al., 2008; Njie-Mbye et al., 2010; Njie-Mbye et al., 2012; Ohia et al., 2010; Opere et al., 2009).  In a recent study, we found that both slow releasing- (GYY 4137) and fast-releasing (NaHS) H2S donors can relax the precontracted isolated long posterior ciliary artery (PCA) ( ADDIN REFMGR.CITE Chitnis et al., 2013). Furthermore, we showed that the GYY4137-mediated relaxation of pre-contracted PCA was dependent upon the production of excitatory endogenous prostanoids and that this response was due, at least in part, on the endogenous biosynthesis of H2S by CBS and CSE and by an action of the release gas on KATP channels ( ADDIN REFMGR.CITE Chitnis et al., 2013).  There is evidence that H2S can interact with other gaseous molecules such as nitric oxide (NO) and carbon monoxide (CO) in exerting physiological and pharmacological actions in ocular tissues ( ADDIN REFMGR.CITE Bucolo & Drago, 2011; Pong & Eldred, 2009; Salomone et al., 2014). In the rabbit ophthalmic artery, Salomone et al.(2014) reported that CO can synergize with NO to induce relaxations whereas H2S counteracted the actions of endogenous NO.  Taken together, it appears that the pharmacological actions induced by H2S donors in the ocular vasculature may involve a cross talk between H2S, NO and CO.






	Propargylglycine (PAG), aminooxyacetic acid (AOAA), NaHS, S-adenosyl-L-methionine (SAM), glibenclamide and L-nitroarginine methyl ester (L-NAME) were all purchased from Sigma Aldrich, St. Louis, MO. Flurbiprofen was procured from Cayman Chemicals, Ann Arbor, MI. All test agents were freshly prepared immediately before use on the day of the study. Stock solution of NaHS, AP67 and AP72 were prepared in distilled water whilst all other compounds were prepared in 70% ethanol. Vehicle controls were prepared using 0.1% saline.

Tissue preparation
	Bovine eyes were obtained from Vision Tech, Dallas, TX within 24h following enucleation and transported to the laboratory (shipped on ice). The medial or lateral long posterior ciliary arteries were dissected free from the optic nerve at a distance of 2 cm from the posterior aspect of the globe of each eye. The fatty and connective tissues were removed and the vessel with attached endothelium was cut into strips of 2 mm length and placed in oxygenated Krebs solution maintained at  37 ºC as described by Dalske, 1974).

Measurement of isometric tension
Posterior ciliary artery rings (2 mm long) were prepared for muscle contraction/relaxation studies using a 25 ml organ bath containing oxygenated Krebs solution (pH 7.4) at 37 ºC. Two vessel rings were prepared from each eyeball. In brief, vascular rings were mounted on two tungsten wires (with one wire immobilized and the other connected to a Grass FT03 transducer) for measurement of isometric tension using a Grass Polyview Software. The Krebs solution had the following composition (mM): potassium chloride, 4.8; sodium chloride, 118; calcium chloride, 2.5; potassium dihydrogen phosphate, 1.2; sodium bicarbonate, 25; magnesium sulfate, 2.0; and dextrose, 10. Each ciliary artery ring preparation was mechanically stretched to achieve a basal tension of 5.0 g and then allowed to equilibrate for 45 minutes before the start of the experiment. Ciliary artery rings were pre-contracted with sub-maximal concentrations of the adrenoceptor receptor agonist, phenylephrine to induce tone, and then exposed to different concentration of H2S-donors for 2-5 minutes or until the development of a stable tone.  When used, enzyme inhibitors, activator or ion channel blockers were incubated with the vascular segments for 30 minutes before exposure to H2S-donors.








	In the present study, we studied the inhibitory effects of slow-releasing H2S donors, AP67 and AP72 in the presence of tone induced by submaximal concentrations of the adrenoceptor agonist, phenylephrine.  A submaximal concentration of phenylephrine was established in each preparation and it generally corresponded to doses that elicited 60-80% of the maximum contractile response.  We also compared the inhibitory actions of the slow-releasing H2S donors with that of its fast-releasing counterpart, NaHS in bovine PCAs.  NaHS (1 nM - 10 µM), AP67 (1 nM - 10 µM) and AP72 (10 nM - 1 µM) produced a concentration-dependant relaxation of phenylephrine-induced tone with IC50 values of 0.16 ± 0.02 µM (n = 6), 0.08 ± 0.04 µM (n = 8) and 4.3 ± 0.9 nM (n = 8), respectively (Figure 2). 


Effect of cyclooxygenase inhibition
	We next examined the role of the COX inhibitor, flurbiprofen on relaxation induced by NaHS, AP67 and AP72. On its own, flurbiprofen (3 µM) had no significant action on the tone induced by phenylephrine. In the presence of flurbiprofen (3 µM), concentration-response curves to AP67 was shifted to the right and IC50 values were increased significantly (p < 0.05) from 0.08 ± 0.04 µM (n = 8) to 200 ± 64 nM (n = 6) (Figure 3A). In contrast, flurbiprofen (3 µM) had no significant effect (p > 0.05) on relaxations induced by AP72 and NaHS (Figures 3B, 3C). 

Role of cystathionine β-synthase and cystathionine γ-lyase

	To determine the role of biosynthetic enzymes of H2S pathway in the pharmacological responses elicited by AP67 and AP72, we studied the relaxations produced by the slow-releasing gas donors in the absence and presence of enzyme inhibitors, aminooxyacetic acid (AOAA) and proparglyglycine (PAG). Both AOAA (30 µM) and PAG (1 mM) had no significant effect on tone induced by phenylephrine. As shown in Figures 4A and 4B, an inhibitor of cystathionine β-synthase, AOAA (30 µM) caused significant (p < 0.05) rightward shifts in the concentration-response curve to AP67 and AP72.   IC50 values were increased from 0.08 ± 0.04 µM (n = 8) to 0.6 ± 0.012 µM (n = 5) for AP67 and from 4.3 ± 0.9 nM (n=8) to 20 ± 2 nM (n=6) for AP72 (Figures 4A and 4B). Likewise, an inhibitor of cystathionine γ-lyase, PAG (1 mM) blocked relaxations induced by AP67 and AP72 as illustrated by significant rightward shifts in the concentration-response curves to these compounds (p < 0.05) (Figures 5A and 5B). Furthermore, the maximal degree of relaxation induced by AP72 was reduced significantly (p < 0.05) from 80 % ± 5.6% to 50% ± 3.6% (n = 8) at a concentration of 100 nM (Figure 5B).   We next studied the effect of an activator of cystathionine β-synthase, S-adenosylmethionine (SAM, 100 µM), on AP67 and AP72- induced relaxation. On its own, SAM (100 µM) had no significant action on tone induced by phenylephrine. In concentrations up to 100 µM, SAM had no significant effect on relaxations induced by AP67 and AP72. [For AP67: IC50 in the absence of SAM: 0.08 ± 0.04 µM (n = 8) and IC50 in the presence of SAM:  0.1± 0.05 µM (n= 6); For AP72: IC50 in the absence of SAM: 4.3 ± 0.9nM (n= 8) and IC50 in the presence of SAM:  3 ± 1.5nM (n= 6)].


Role of ATP-sensitive K+ (KATP) channel and nitric oxide

	There is evidence that KATP channel may be involved in vasorelaxant effect of H2S in several mammalian tissues ( ADDIN REFMGR.CITE Zhao et al., 2001), and that H2S may induce vasorelaxation in synergy with nitric oxide (NO) (Zhao & Wang, 2002). We investigated the effect of L-NAME, a nitric oxide synthase inhibitor and glibenclamide, a KATP channel blocker on relaxations induced by AP67 and AP72 in isolated bovine PCAs.  Both L-NAME (100 µM) and glibenclamide (300 µM) had no significant effect on the tone induced by phenylephrine.
 	L-NAME (100 μM) significantly attenuated (p < 0.05) the relaxations induced by AP67 and AP72 on bovine PCAs and increased IC50 values from of 0.08 ± 0.04 µM (n = 8) to 5.4 ± 2.0 µM (n=5) for AP67 and from 4.3 ± 0.91nM (n=8) to 90 ± 40 nM (n=8) for AP72 (Figures 6A and 6B). Furthermore, the maximal degree of relaxation induced by AP67 was reduced significantly (p < 0.05) from 76 ± 5% to 45 ± 5 % (n = 8) at a concentration of 1 µM (Figure 6A).    
As shown in Figures 7A and 7B, glibenclamide (300 μM) significantly (p < 0.05) blocked relaxations of phenylephrine-induced tone elicited by AP67 and AP72 and increased IC50 values from 0.08 ± 0.04 µM (n = 8) to 0.9± 0.07 µM (n=8) for AP67 and from 4.3 ± 0.9 nM (n = 8) to 0.6 ± 0.2 µM (n = 12) for AP72.
Discussion

	For several decades, hydrogen sulfide (H2S) gas was considered as a toxic substance until recent reports from several laboratories provided evidence for its beneficial biological role in several mammalian tissues and organs.  Indeed, H2S is now recognized as a potential gaseous transmitter (with gases such as nitric oxide and carbon monoxide) which plays an important role in normal physiological processes at low concentrations (Qu et al., 2008). In its physiological role, H2S is produced in astrocytes, neurons and microglia, and it can act as an endogenous anti-inflammatory and neuroprotective agent ( ADDIN REFMGR.CITE Li et al., 2009). In the eye, H2S is endogenously produced in ocular tissues and there is evidence supporting its pharmacological actions on neurotransmitter release from anterior uveal tissues and the retina ( ADDIN REFMGR.CITE Kulkarni et al., 2009; Monjok et al., 2008; Njie-Mbye et al., 2010; Njie-Mbye et al., 2012; Ohia et al., 2010; Opere et al., 2009) and in protecting the retinal against insults (neuroprotection) ( ADDIN REFMGR.CITE Osborne et al., 2010; Perrino et al., 2009). Perrino et al. (2009) showed that ACS 67, a H2S-releasing derivative of latanoprost caused a higher decrease in IOP than the parent compound in two glaucomatous rabbit models suggesting a role for H2S in the regulation of IOP.  We have evidence that GYY4137, a novel slow-releasing H2S donor can relax pre-contracted isolated bovine PCAs ( ADDIN REFMGR.CITE Chitnis et al., 2013). The PCA is a very important part of ocular blood flow and changes in vascular reactivity in these vessels can result in a variety of ocular disorders leading to vision loss.   
Most studies in biomedical literature have used NaHS or Na2S (sulfide salts) as “tools” to model the biological effects of endogenous H2S gas. For instance, NaHS releases large amounts of H2S in a short duration of time. However, the release of endogenous H2S from cells may occur in lesser amounts and at a much slower rate than that from sulfide salts. Consequently, the release of H2S from sulfide salts may not mimic the biological effects of endogenously produced H2S. Recently, the availability of compounds that can release H2S slowly (e.g. AP67 and AP72) in biological systems have led to further studies of the pharmacology of these new class of gas donors ( ADDIN REFMGR.CITE Li et al., 2009; Li et al., 2008). In the present study, we investigated the pharmacological actions of novel slow-releasing H2S donors, AP67 and AP72 on pre-contracted isolated bovine PCAs.  We also compared the relaxations induced by AP67 and AP72 with that of the fast-releasing H2S donor, NaHS.
We found that H2S donors, NaHS, AP67 and AP72 produced a concentration-dependent relaxation of phenylephrine-induced tone in PCA with the following rank order of potency: AP72 > AP67 > NaHS. The slow-releasing H2S donors, AP67 and AP72 were more potent than NaHS in relaxing the pre-contracted ciliary arteries, presumably because the ciliary arteries were exposed to H2S over a longer period of time due to the sustained-release nature of these compounds.  Other investigators have reported a similar high potency of a slow-releasing H2S donor, GYY4137 in comparison to NaHS, on relaxing pre-contracted rat aortic rings and in evaluating their antitumor activity in human cancer cell lines ( ADDIN REFMGR.CITE Li et al., 2009; Li et al., 2008). It is pertinent to note that high concentrations of GYY4137 (1 mM) has been reported by Salomone et al., 2014) to potentiate phenylephrine-induced tone in rabbit ophthalmic arteries. However, it remains to be determined whether effects elicited by such higher concentrations of GYY4137 could be related to its pharmacological actions as a H2S donor. Be that is it may, the higher potency of slow-releasing H2S donors in relaxing pre-contracted blood vessels affirm their important roles as tools in studying the biology of this gas in experimental animals and humans.
To elucidate the mechanism of the relaxant action of H2S donors, we considered the possible involvement of prostanoids in this response. In blood vessels, it has been postulated that the vasodilatory effects of H2S may involve other second messengers such as nitric oxide, prostanoids, bradykinin ( ADDIN REFMGR.CITE Bhatia, 2005; Kiss et al., 2008; Wang et al., 2008). It is well established that prostanoids play an important role in the relaxation of vascular smooth muscles to H2S donors (Koenitzer et al., 2007). Indeed, prostanoids have been shown to be involved in the relaxation of ciliary arteries ( ADDIN REFMGR.CITE Abe et al., 2013). In the present study, we examined the possibility that intramurally generated prostanoids may contribute to our observed relaxant effects of AP67, AP72 and NaHS on pre-contracted PCA.  Flurbiprofen shifted the inhibitory concentration-response curves of AP67 to the right suggesting that endogenous production of excitatory prostanoids may be involved in its responses. It is pertinent to note that only responses to low concentrations of AP67 were blocked by flurbiprofen. Conversely, we found that flurbiprofen had no effect on relaxations induced by NaHS or AP72 in PCA. While there is evidence that NaHS can stimulate prostanoids release in mouse hind paws ( ADDIN REFMGR.CITE di Villa et al., 2010), it is unclear why flurbiprofen had no effect on its response in the PCA.  Furthermore, the differential actions of flurbiprofen on the inhibitory response induced by AP67 and AP72 were unexpected. In a previous study, we showed evidence that prostanoids are involved in the relaxations caused by H2S donors and its substrate (L-cysteine) in the isolated iris-ciliary body ( ADDIN REFMGR.CITE Chitnis et al., 2013; Monjok et al., 2008; Ohia et al., 2010).  It may well be that the observed differences in actions of AP67 and AP72 to prostanoids could be due to additional non-specific action of AP67 on PCA and/or to an enhanced ability of AP67 to generate H2S in physiological buffers when compared to AP72 (Whiteman et al., 2015). Taken together, it appears that tissue differences may exist in the ability of H2S donors to interact with the pathways leading to the production of prostanoids. 
The availability of inhibitors of enzymes of the biosynthetic pathways for H2S has enabled studies to be performed on the involvement of this gas in responses produced by its donors ( ADDIN REFMGR.CITE Kimura et al., 2005; Lowicka & Beltowski, 2007). In the current study, both the inhibitors of CBS and CSE blocked relaxations caused by AP67 and AP72 thus indicating that  the production of endogenous H2S which may contribute, at least in part, to the responses elicited by these compounds  in bovine PCA. Other investigators have reported that inhibitors of CBS and CSE can attenuate responses produced by NaHS on vascular and non-vascular smooth muscles ( ADDIN REFMGR.CITE Dawe et al., 2008; Srilatha et al., 2007; Teague et al., 2002; Webb et al., 2008). For instance, at concentrations of 1 mM, the CSE inhibitor, PAG, inhibited not only the vasodilatory effects of NaHS but it also blocked the in situ production of H2S ( ADDIN REFMGR.CITE Srilatha et al., 2007; Teague et al., 2002; Webb et al., 2008). Taken together, our results demonstrate that the inhibitory actions of AP67 and AP72 in PCA are dependent upon the endogenous biosynthesis of H2S. 
Various pharmacological studies have demonstrated that activators of CBS such as SAM can lead to an increase in H2S production in several mammalian tissues ( ADDIN REFMGR.CITE Abe & Kimura, 1996; Jensen et al., 2011; Kulkarni et al., 2011). In addition, evidence from our laboratory demonstrates that SAM can enhance relaxations caused by NaHS in isolated porcine irides ( ADDIN REFMGR.CITE Monjok et al., 2008). In the present study, we examined the effect of SAM on AP67- and AP72-induced relaxations of the phenylephrine tone. We observed that SAM had no effect on relaxations induced by both AP67 and AP72. In a recent study, we also found that SAM did not alter the relaxation elicited by another H2S donor, GYY4137 in bovine PCA. The lack of an effect of SAM on relaxations induced by these H2S donors suggests that species and tissue differences may exist in the response of PCAs to AP67 and AP72. 
There is evidence that H2S promotes vasorelaxation by directly opening ATP-sensitive K+ (KATP) channels or voltage dependent K+ channels ( ADDIN REFMGR.CITE Cheng et al., 2004; Zhao et al., 2001). In addition, studies from our laboratory have shown that glibenclamide, a specific KATP channel antagonist, attenuated relaxations induced by H2S donors (NAHS and GYY4137) and the H2S substrate (L-cysteine) on ocular smooth muscles ( ADDIN REFMGR.CITE Chitnis et al., 2013; Ohia et al., 2010). In the present study, we investigated the effect of glibenclamide on relaxations induced by AP67 and AP72.  We found that glibenclamide blocked relaxations of phenylephrine-induced tone elicited by AP67 and AP72. A similar glibenclamide-induced antagonism of relaxations induced by H2S donors (GYY4137 and NaHS) has been reported in other vascular beds ( ADDIN REFMGR.CITE Chen et al., 2005; Ghasemi et al., 2012; Li et al., 2008; Tang et al., 2005; Webb et al., 2008). Since data from the present study demonstrates a role for NO in the relaxations induced by AP67 and AP72, it is important to highlight the observation by Murphy & Brayden (1995) in which they reported that NO caused hyperpolarization of rabbit mesenteric arteries by activating KATP channels. It is, therefore, tempting to speculate that the effect of AP67 and AP72 on KATP channels may be due to a direct action on these channels and/or an indirect effect on the channels through the release of NO. In contrast, other investigators have found that the relaxations caused by H2S in the guinea-pig ileum and trout urinary bladder were not mediated by KATP channels ( ADDIN REFMGR.CITE Dombkowski et al., 2006; ,Teague et al., 2002). The observed sensitivity of relaxations induced by AP67 and AP72 to glibenclamide indicates that KATP channels partially mediate these responses in the isolated bovine PCA. Taken together, it appears that species and tissue differences may exist in the ability of H2S to interact with KATP channels. 
It is well known that H2S and NO are vasorelaxant factors that possess the ability to ‘cross talk’ through formation of a nitrosothiol moiety (Whiteman et al., 2006). However, there are conflicting reports in biomedical literature pertaining to the pharmacological outcomes of this interaction. For instance, some studies on the thoracic aorta of rats report that H2S can enhance the vasorelaxant effect of NO (Hosoki et al., 1997), whilst others report that H2S reduced NO induced vasorelaxation ( ADDIN REFMGR.CITE Ali et al., 2006; Zhao & Wang, 2002). In the present study, we examined the effect of L-NAME, a NO synthase inhibitor, on relaxations induced by AP67 and AP72.    L-NAME shifted the concentration response curves of AP67 and AP72 to the right suggesting that endogenous NO may be involved in its responses. In support of this observation, other investigators have shown that H2S-induced vascular response was reduced by NO inhibitors in rat aorta, ileum, liver and vascular tissues ( ADDIN REFMGR.CITE Ali et al., 2006; Chen et al., 2005; Hosoki et al., 1997; Whiteman et al., 2006; Zhao et al., 2003; Zhao et al., 2001). Interestingly, previous studies from our laboratory have reported that, L-NAME did not alter the relaxation effects of NaHS and L-cysteine in isolated porcine irides (Ohia et al.,2010; Monjok et al., 2008;  ADDIN REFMGR.CITE Chitnis et al., 2013). In the salamander retina, Pong & Eldred (2009) found that NaHS reduced NO-induced cGMP-like immunoreactivity, a response that was not significantly affected by the addition of CuCl2 indicating that the decrease caused by the H2S donor was not due to the sequestering of H2S and NO to form a novel nitrosothiol. In the rabbit ophthalmic artery,Salomone et al. (2014) found that the ability of a high concentration of GYY4137 to potentiate phenylephrine-induced contractions was unaffected by the presence of NG-nitro-L-arginine (LNNA).  Furthermore, relaxations of residual tone in the rabbit ophthalmic artery by acetylcholine and sodium nitroprusside (in the presence of LNNA) was not blocked by GYY4137 (1 mM). Based on these observations,Salomone et al. (2014) suggested that GYY4137 interfered with basal release of NO, an action that occurred upstream of guanylyl cyclase. It is important to note that at a lower concentration of GYY4137 (100 µM) had no direct effect on cGMP accumulation in the rat isolated aorta (Li et al., 2008). Be that as it may, observations made in the present study about an interaction of AP67 and AP72 with the NO pathway indicates that NO accounts at least, in part, for the pharmacological actions of these donors in the isolated bovine PCA. 
We conclude that H2S donors NaHS, AP67 and AP72 can relax pre-contracted isolated bovine ciliary artery, an effect dependent on endogenous production of H2S. The inhibitory action of AP67 (but not that of AP72 and NaHS) on pre-contracted PCA involves the production of inhibitory endogenous prostanoids. Furthermore, the observed inhibitory action of AP67 and AP72 on ciliary arteries is dependent, at least in part, on the endogenous biosynthesis of NO and by an action of KATP channels.
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Figure Legends.
Figure 1:Chemical Structure of AP67 {(4-methoxyphenyl)pyrrolidin-1-ylphosphinodithioc acid} and AP72 {(4-methoxyphenyl)piperidin-1-ylphosphinodithioc acid)}

Figure 2: Concentration-dependent relaxation of phenylephrine-induced tone in isolated bovine ciliary artery by H2S donors AP67, AP72 and NaHS. Vertical bars represent means ± S.E.M.; n= 6-36.
Figure 3: Concentration-dependant relaxation of phenylephrine-induced tone in isolated bovine ciliary artery by H2S donors (A) AP67, (B) AP72 and (C) NaHS: control, and in the presence of flurbiprofen (FBF, 3 µM). FBF blocked relaxations induced by lower concentrations of AP67 but not those elicited by AP72 and NaHS. Vertical bars represent means ± S.E.M.; n=6--36. *p<0.05, significantly different from control. 

Figure 4: Effect of aminooxyacetic acid (AOAA) on  (A) AP67 and (B) AP72-induced relaxation of phenylephrine tone in isolated bovine posterior ciliary artery: control, and in the presence of AOAA (30 µM). AOAA blocked relaxations induced by both AP67 and AP72. Vertical bars represent means ± S.E.M.; n=5-36. *p<0.05, significantly different from control.  

Figure 5: Effect of propargylglycine (PAG) on  (A) AP67 and (B) AP72-induced relaxation of phenylephrine tone in isolated bovine posterior ciliary artery: control, and in the presence of PAG (1 mM). PAG blocked relaxations induced by both AP67 and AP72. Vertical bars represent means ± S.E.M.; n=8-36. *p<0.05, significantly different from control. 

Figure 6: Effect of L-NAME on  (A) AP67 and (B) AP72-induced relaxation of phenylephrine tone in isolated bovine posterior ciliary artery: control, and in the presence of L-NAME (100 µM). L-NAME blocked relaxations induced by both AP67 and AP72. Vertical bars represent means ± S.E.M.; n=5-36. *p<0.05, significantly different from control. 

Figure 7: Effect of glibenclamide (GLIB) on (A) AP67 and (B) AP72-induced relaxation of phenylephrine tone in isolated bovine posterior ciliary artery: control, and in the presence of GLIB (300 µM). GLIB blocked relaxations induced by both AP67 and AP72. Vertical bars represent means ± S.E.M.; n=6-36. *p<0.05, significantly different from control.  






Figure 2









AP67

AP72

Figure 1

Figure 3

A

B

C

Figure 4

B

A

Figure 5

B

A

A



B

Figure 6

Figure 7

B

A



28



